Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
DelNova Logo
DelNova CB Rank
96913
Heat Score
67
DelNova is a therapeutics company that solves unmet medical needs.
Founded
obfuscation
PrivateVenture - Series Unknown Illinois City, Illinois, United States11-50 www.delnova.net
Biotechnology
Delivery
Health Care
Medical
Staffing Agency
Overview

DelNova
Total Funding
obfuscation
Heat Score
67

Total Funding
obfuscation
obfuscation
Venture - Series Unknown raised
obfuscation
Growth Score
pts
in past quarter
Heat Score 67
-11 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About DelNova

CB Rank
96913
DelNova is a therapeutics company that solves unmet medical needs.
Founded
obfuscation
PrivateVenture - Series Unknown Illinois City, Illinois, United States11-50 www.delnova.net
Biotechnology
Delivery
Health Care
Medical
Staffing Agency

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation

Key People

Details

Legal Name DelNova, Inc.
Operating Status Active
Company Type For Profit
Founders  Mary Gardner
About the Company
DelNova is developing proprietary therapies by leveraging advances in drug delivery technology. They have identified an anticholinesterase class of drugs as a means of accelerating muscle recovery by indirectly increasing the neurotransmitter deficit caused by botulinum toxin.
Diversity Spotlight 
Women Founded
Women Led
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

ReViVox®
A therapeutic product designed to counteract complications from off-target muscle paralysis caused by botulinum-Type A neurotoxin therapies.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - DelNova Logo
Venture Round - DelNova
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - DelNova Logo
Venture Round - DelNova
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - DelNova Logo
Venture Round - DelNova
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - DelNova Logo
Venture Round - DelNova
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - DelNova Logo
Venture Round - DelNova
—
obfuscation
— Venture - Series Unknown

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - DelNova Logo
Venture Round - DelNova
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - DelNova Logo
Venture Round - DelNova
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - DelNova Logo
Venture Round - DelNova
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - DelNova Logo
Venture Round - DelNova
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - DelNova Logo
Venture Round - DelNova
—
obfuscation
— Venture - Series Unknown

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 2 Contacts 1

Employee Profiles

News
Technology
View Tech Report

IT Spend

$118KThis year, DelNova is projected to spend $118K on IT, according to Aberdeen.

Active Website Tech Count

26DelNova is actively using 26 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, Viewport Meta, and  SSL by Default.

Total IP

4The intellectual property of DelNova includes 3 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, DelNova has 1 registered trademark in the 'Scientific and technological services' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is DelNova's headquarters? DelNova is located in Illinois City, Illinois, United States.When was the last funding round for DelNova? DelNova closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are DelNova's competitors? Alternatives and possible competitors to DelNova may include Galderma, AbbVie, and  Autonomous a2z.How much funding has DelNova raised to date? DelNova has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(9fd75b2 1)
|